Updated:
DoseSpot
DoseSpot provides an embedded e-prescribing platform for dental and specialty practices, serving over 200,000 providers via API integrations.
DoseSpot
DoseSpot was founded in 2012 and is led by CEO and President Gregory T. Rau, a veteran healthcare technology executive. The company emerged as a specialized electronic prescribing platform built explicitly for dental, veterinary, mental health, and other ambulatory specialty providers who were underserved by broad enterprise EHR prescribing modules. The platform connects directly to the Surescripts network, enabling real-time electronic prescribing of controlled and non-controlled substances, prescription benefit checks, and medication history retrieval. Its core deployment model is an embeddable API and white-label solution that integrates into existing practice management systems — a strategy that made it the de facto e-prescribing engine for many leading dental and specialty software vendors. Confirmed integrations and partnerships include Dentrix, Eaglesoft, and Open Dental, making the firm deeply embedded in the dental DSO (Dental Service Organization) ecosystem. DoseSpot's reach spans all 50 US states, with full support for EPCS (Electronic Prescribing for Controlled Substances) compliance. DoseSpot was acquired by MD Toolbox in a 2021 transaction that combined two complementary e-prescribing platforms — MD Toolbox's strength in physician practices with DoseSpot's dominance in dentistry and veterinary medicine. In February 2023, Rau was appointed CEO of the combined entity, signaling a continued investment in the DoseSpot brand and integration platform. The firm does not publicly disclose revenue or total processed transactions, but its integration footprint makes it one of the largest specialty-specific prescribing networks in the country. Structurally, DoseSpot differs from most healthcare IT firms in its singular API-first, embedded approach rather than a standalone user-facing application. This positions it as a middleware layer rather than a destination product, creating high switching costs inside its partner ecosystems. The company operates on a recurring SaaS licensing model, with transactions flowing through its certified connection to the Surescripts pharmacy network.
General information
Firm type
Asset Manager
Year founded
2012
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Needham
Corporate office
Needham, MA, United States
Principals
Gregory T. Rau
CEO & President
Sector focus
Frequently asked questions
How does DoseSpot's integration model differ from standalone e-prescribing apps?
DoseSpot operates as an embeddable API and white-label solution rather than a standalone e-prescribing application. It integrates directly into existing practice management and clinical software, allowing providers to prescribe without leaving their primary workflow. This embedded model is particularly prevalent in dentistry and veterinary medicine, where major PMS platforms such as Dentrix and Eaglesoft rely on DoseSpot to power their native prescribing modules.
Which provider segments does DoseSpot primarily serve?
DoseSpot focuses on dental, veterinary, mental health, and other ambulatory specialty practices. While competing platforms often target broad physician markets, DoseSpot has built a specialized network optimized for the regulatory and workflow requirements of dentists, veterinarians, and behavioral health providers — segments where controlled substance prescribing and state-specific EPCS mandates create high demand for compliant solutions.
How is DoseSpot connected to the broader pharmacy network?
DoseSpot operates as a certified Surescripts network partner, which serves as the clearinghouse connecting prescribers to pharmacies and pharmacy benefit managers across the United States. Through this connection, DoseSpot enables real-time electronic prescribing, eligibility checks, formulary information, and medication history retrieval for its network of over 200,000 providers.
Does DoseSpot support electronic prescribing for controlled substances (EPCS)?
Yes. DoseSpot is certified for Electronic Prescribing of Controlled Substances (EPCS) and has full compliance with the DEA's requirements for two-factor authentication and identity proofing. This certification is critical for the dental and specialty markets where opioid and other controlled substance prescribing is a significant portion of clinical workflow, and where state mandates increasingly require electronic prescribing.
What was the strategic rationale behind the DoseSpot–MD Toolbox combination?
In 2021, DoseSpot was acquired by MD Toolbox, bringing together DoseSpot's strength in dental, veterinary, and specialty e-prescribing with MD Toolbox's established presence in physician practices. The combination created a platform covering a wider breadth of provider types, though each brand continues to operate in its respective market segments with shared infrastructure and technical leadership under CEO Gregory Rau.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: